Advanced Registry Search Results
Search Criteria
- Lobbyist name (consultant or in-house lobbyist): FRALICK, PAMELA OR;
- Senior Officer name: FRALICK, PAMELA
Refine By
Document Type
Registrations Status
Activity Type
Subject Matter of the Lobbying Activity
Ministries/Provincial Entities
If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search
Advanced Registry Search Results
Results: 1-50 of 50
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
-
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 9 of 58 (2019-11-20 to2020-05-04 )
Posted: 2019-11-20Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 8 of 58 (2019-05-10 to2019-11-10 )
Posted: 2019-05-10Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 7 of 58 (2018-10-18 to2019-04-18 )
Posted: 2018-10-18Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 6 of 58 (2018-03-27 to2018-09-27 )
Posted: 2018-03-28Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 5 of 58 (2017-09-25 to2018-03-25 )
Posted: 2017-09-25Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 4 of 58 (2017-03-22 to2017-09-18 )
Posted: 2017-03-22Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Innovative Medicines Canada (Medicaments novateurs Canada)
Activity type: Organization
Senior Officer: Pamela Fralick
Registration: 3 of 58 (2016-09-22 to2017-03-21 )
Posted: 2016-09-22Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
- Date Modified: